Position in ASND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,372,607
+$622,808 QoQ
Shares Held
16,394
0.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#125
of 309 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $127,577,689 across 7 Biotechnology names. ASND ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
97,334 | $48,348,717 | |
| 2 | RPRX |
Royalty Pharma plc
|
579,801 | $32,509,442 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
77,161 | $21,988,570 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,166 | $8,779,840 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,665 | $8,520,674 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
16,394 | $4,372,607 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
56,066 | $3,057,839 |
All Filings in ASND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,372,607 | 16,394 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,749,799 | 16,394 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,595,439 | 16,861 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,308,610 | 21,672 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,537,954 | 20,498 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,148,527 | 20,201 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,636,793 | 19,153 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||